Align Technology Stock Price, News & Analysis (NASDAQ:ALGN)

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Align Technology, Inc. (NASDAQ:ALGN) posted its earnings results on Wednesday, July, 24th. The medical equipment provider reported $1.26 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.13 by $0.13. The medical equipment provider had revenue of $600.70 million for the quarter, compared to analyst estimates of $599.86 million. Align Technology had a return on equity of 29.26% and a net margin of 19.06%. The business's revenue was up 22.5% compared to the same quarter last year. During the same period last year, the company earned $1.30 earnings per share. View Align Technology's Earnings History.

Align Technology is scheduled to release their next quarterly earnings announcement on Wednesday, October 23rd 2019. View Earnings Estimates for Align Technology.

Align Technology issued an update on its third quarter earnings guidance on Wednesday, July, 24th. The company provided earnings per share (EPS) guidance of $1.09-1.16 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.45. The company issued revenue guidance of $585-600 million, compared to the consensus revenue estimate of $623.83 million.

13 Wall Street analysts have issued twelve-month target prices for Align Technology's stock. Their predictions range from $210.00 to $420.00. On average, they anticipate Align Technology's share price to reach $294.40 in the next year. This suggests a possible upside of 57.8% from the stock's current price. View Analyst Price Targets for Align Technology.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Align Technology.

Media stories about ALGN stock have trended somewhat negative recently, InfoTrie Sentiment reports. The research firm ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Align Technology earned a news impact score of -1.3 on InfoTrie's scale. They also assigned news headlines about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Align Technology.

Some companies that are related to Align Technology include Edwards Lifesciences (EW), Zimmer Biomet (ZBH), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), Steris (STE), DEMANT A S/ADR (WILYY), MSA Safety (MSA), Wright Medical Group (WMGI), Avanos Medical (AVNS), Inogen (INGN), Establishment Labs (ESTA), Sientra (SIEN), Invacare (IVC), RTI Surgical (RTIX) and ConforMIS (CFMS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), Micron Technology (MU), Adobe (ADBE), Paypal (PYPL), Visa (V), salesforce.com (CRM), Mastercard (MA) and Boeing (BA).

Align Technology's stock is owned by many different of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (9.93%), BlackRock Inc. (8.90%), BlackRock Inc. (8.90%), Private Advisor Group LLC (4.74%), Edgewood Management LLC (3.86%) and Polen Capital Management LLC (3.26%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Simon Beard, Sreelakshmi Kolli, Stuart A Hockridge, Thomas M Prescott, Vamsi Mohan Raj Pudipeddi, Warren S Thaler and Yuval Shaked. View Institutional Ownership Trends for Align Technology.

ALGN stock was sold by a variety of institutional investors in the last quarter, including Viking Global Investors LP, Winslow Capital Management LLC, Price T Rowe Associates Inc. MD, Janus Henderson Group PLC, Janus Henderson Group PLC, BlackRock Inc., BlackRock Inc. and Bamco Inc. NY. Company insiders that have sold Align Technology company stock in the last year include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, Greg J Santora, John Morici, Joseph Lacob, Julie Tay, Raphael Pascaud, Sreelakshmi Kolli, Warren S Thaler and Yuval Shaked. View Insider Buying and Selling for Align Technology.

ALGN stock was acquired by a variety of institutional investors in the last quarter, including Private Advisor Group LLC, Edgewood Management LLC, Nuveen Asset Management LLC, Invesco Ltd., Renaissance Technologies LLC, Man Group plc, Bessemer Group Inc. and Worldquant Millennium Advisors LLC. Company insiders that have bought Align Technology stock in the last two years include Joseph M Hogan and Vamsi Mohan Raj Pudipeddi. View Insider Buying and Selling for Align Technology.

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ALGN stock can currently be purchased for approximately $186.54.

Align Technology has a market capitalization of $14.90 billion and generates $1.97 billion in revenue each year. The medical equipment provider earns $400.23 million in net income (profit) each year or $4.92 on an earnings per share basis. Align Technology employs 11,660 workers across the globe.View Additional Information About Align Technology.

The official website for Align Technology is http://www.aligntech.com/.

Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The medical equipment provider can be reached via phone at 408-470-1000 or via email at [email protected]